1-3 of 3
Robert Fenton, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Effect of the Proteasome Inhibitor Bortezomib in Combination with “DT-PACE” on Stem Cell Collection and Engraftment in Newly Diagnosed Multiple Myeloma (MM) Patients (Pts).

Ashrof Z. Badros, MD, Javier Bolaños-Meade, MD, Aaron Rapoport, MD, Bashi Ratterree, RN, Sabrina Natt, RN, Kathy Ruehle, RN, Kathy McNamara, RN, Edmund Cox, Sandy Westphal, Robert Fenton, MD, PhD, Barry Meisenberg, MD.
Journal: Blood
Blood (2004) 104 (11): 5007.
https://doi.org/10.1182/blood.V104.11.5007.5007
Published: 2004
Journal Articles

Phase II Trial of Oblimersen Sodium (G3139), Dexamethasone (Dex) and Thalidomide (Thal) in Relapsed Multiple Myeloma Patients (Pts).

Ashrof Z. Badros, MD, Olga Goloubeva, PhD, Bashi Ratterree, RN, Sabrina Natt, RN, Aaron Rapoport, MD, Javier Bolaños-Meade, MD, Ben Zhang, PhD, Jerry Zeldis, MD, PhD, Stanley Frankel, MD, Barry Meisenberg, MD, James Zwiebel, MD, J. Flaws, PhD, D. Tomic, PhD, Robert Fenton, MD, PhD
Journal: Blood
Blood (2004) 104 (11): 2400.
https://doi.org/10.1182/blood.V104.11.2400.2400
Published: 2004
Journal Articles

The Lack of Clinical Efficacy of Flavopiridol in Patients with Relapsed Refractory Myeloma.

Angela Dispenzieri, MD, Keith C. Bible, MD, PhD, Martha Q. Lacy, MD, Tom R. Fitch, MD, Susan M. Geyer, PhD, Robert Fenton, MD, Rafael Fonseca, MD, Crescent R. Getman, Steven C. Ziesmer, Charles Erlichman, MD, Morie A. Gertz, MD
Journal: Blood
Blood (2004) 104 (11): 3461.
https://doi.org/10.1182/blood.V104.11.3461.3461
Published: 2004